ATLAS / Macro Radar / Reporting / LCTX

Lineage Cell Therapeutics, Inc. (LCTX) reporting calendar

Lineage Cell Therapeutics, Inc. files periodic reports with the SEC as LCTX on NYSE. Atlas tracks 56 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
27 Jul 2026 – 28 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
12 May 2026
Reports on record
56

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open LCTX market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll NYSE reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202612 May 202642 days0001193125-26-219479
10-K31 Dec 20255 Mar 202664 days0001193125-26-093992
10-Q30 Sep 20256 Nov 202537 days0001193125-25-269599
10-Q30 Jun 202512 Aug 202543 days0000950170-25-107333
10-Q31 Mar 202513 May 202543 days0000950170-25-070378
10-K31 Dec 202410 Mar 202569 days0000950170-25-036309
10-Q30 Sep 202414 Nov 202445 days0000950170-24-127077
10-Q30 Jun 20248 Aug 202439 days0000950170-24-094004
10-Q31 Mar 20249 May 202439 days0000950170-24-056998
10-K31 Dec 20237 Mar 202467 days0000950170-24-027988
10-Q30 Sep 20239 Nov 202340 days0001493152-23-040058
10-Q30 Jun 202310 Aug 202341 days0001493152-23-027552
10-Q31 Mar 202311 May 202341 days0001493152-23-016392
10-K31 Dec 20229 Mar 202368 days0001493152-23-007129
10-Q30 Sep 202210 Nov 202241 days0001493152-22-031359
10-Q30 Jun 202211 Aug 202242 days0001493152-22-022085
10-Q31 Mar 202212 May 202242 days0001493152-22-013041
10-K31 Dec 202110 Mar 202269 days0001493152-22-006520
10-Q30 Sep 202110 Nov 202141 days0001493152-21-027859
10-Q30 Jun 202112 Aug 202143 days0001493152-21-019518
10-Q31 Mar 202113 May 202143 days0001493152-21-011299
10-K31 Dec 202011 Mar 202170 days0001493152-21-005814
10-Q30 Sep 20204 Nov 202035 days0001641172-20-000034
10-Q30 Jun 20206 Aug 202037 days0001493152-20-014858
10-Q31 Mar 20207 May 202037 days0001493152-20-007956
10-K31 Dec 201912 Mar 202072 days0001493152-20-003818
10-Q30 Sep 201912 Nov 201943 days0001493152-19-016930
10-Q30 Jun 20198 Aug 201939 days0001493152-19-011906
10-Q31 Mar 20199 May 201939 days0001493152-19-006673
10-K31 Dec 201814 Mar 201973 days0001493152-19-003335
10-Q30 Sep 20188 Nov 201839 days0001493152-18-015428
10-Q30 Jun 20182 Aug 201833 days0001493152-18-010859
10-Q31 Mar 201810 May 201840 days0001493152-18-006559
10-K31 Dec 201715 Mar 201874 days0001493152-18-003416
10-Q30 Sep 20179 Nov 201740 days0001140361-17-041841
10-Q30 Jun 20179 Aug 201740 days0001140361-17-030912
10-Q31 Mar 201710 May 201740 days0001140361-17-019338
10-K31 Dec 201616 Mar 201775 days0001140361-17-012402
10-Q30 Sep 20164 Nov 201635 days0001140361-16-084920
10-Q30 Jun 20169 Aug 201640 days0001140361-16-075508

Source: SEC EDGAR company submissions for CIK 0000876343. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.